-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Heterogeneity of Cells in Transplantation

Program: Scientific Symposia
Session: Cellular Heterogeneity and Relationship to Clinical Outcomes
Sunday, December 8, 2024, 4:30 PM-5:45 PM

Megan Levings

University of British Columbia, Canada, Vancouver, BC, CAN

Disclosures: Levings: Bristol Myers Squibb: Research Funding; Integrated Nanotherapeutics: Current holder of stock options in a privately-held company; Anokion: Membership on an entity's Board of Directors or advisory committees; Sangamo Therapeutics: Patents & Royalties: for A2-CAR constructs.

See more of: Cellular Heterogeneity and Relationship to Clinical Outcomes
See more of: Scientific Symposia
<< Previous Presentation | Next Presentation